| Literature DB >> 19660206 |
Costas D Lallas1, Mark L Pe, Jitesh V Patel, Pranav Sharma, Leonard G Gomella, Edouard J Trabulsi.
Abstract
BACKGROUND AND OBJECTIVES: We report our institutional experience performing transperitoneal robotic-assisted laparoscopic prostatectomy (RALP) in patients with prior prosthetic mesh herniorrhaphy to assess the feasibility of this procedure in this patient population.Entities:
Mesh:
Year: 2009 PMID: 19660206 PMCID: PMC3015950
Source DB: PubMed Journal: JSLS ISSN: 1086-8089 Impact factor: 2.172
Mean Age, Estimated Blood Loss, Console Time, and Length of Stay of Robotic-Assisted Laparoscopic Prostatectomy (RALP) Patients, With and Without Prior Mesh Herniorraphy
| RALP With History of Mesh Herniorrhaphy | RALP Without Mesh Herniorrhaphy | P Value | |
|---|---|---|---|
| Number of Patients | 27 (8.7%) | 282 (91.3%) | |
| Age (years), mean | 55.7 | 59.3 | P = 0.67 |
| Estimated Blood Loss (mL), mean | 227.7 | 301.8 | P = 0.61 |
| Console Time (min), mean | 197 | 187 | P = 0.45 |
| Length of Stay (days), mean | 1.62 | 2.16 | P = 0.51 |
Preoperative and Postoperative Pathologic Comparison of Patients With and Without Mesh Herniorrhaphy
| RALP Without Mesh Herniorrhaphy | P Value | ||
|---|---|---|---|
| Number of patients | 27 (8.7%) | 282 (91.3%) | |
| Preoperative PSA | 6.4 | 6.2 | 0.52 |
| Preoperative clinical stage T1c | 74.1% | 77.0% | 0.74 |
| Pathologic T2 | 51.9% | 82.1% | 0.001 |
| Total positive margin | 18.5% | 15.6% | 0.17 |
| Positive margin pT2 | 7.1% | 11.1% | 0.57 |
| Positive margin pT3/4 | 30.8% | 34.2% | 0.79 |
RALP = robotic-assisted laparoscopic prostatectomy.
Functional Outcomes of Patients With and Without Mesh Herniorrhaphy. One-year Follow-up Demonstrated
| RALP With History of Mesh Herniorrhaphy | RALP Without Mesh Herniorrhaphy | P Value | |
|---|---|---|---|
| Number of Patients | 27 (8.7%) | 282 (91.3%) | |
| Continent (Mean Baseline/Followup IPSS | 89% (9.4/8.4) | 91% (8.6/5.7) | 0.75 |
| Bilateral Nerve Spare | 44% | 60% | 0.13 |
| 83% (59/34) | 81% (55/39) | 0.84 | |
| Unilateral nerve spare | 7.4% | 14.1% | 0.86 |
| 50% (31/26) | 26.7% (44/16) | 0.27 | |
| Non nerve spare | 48.1% | 26.3% | 0.14 |
| 7.7% (42/8) | 9.0% (37/3) | 0.72 |
IPSS = International Prostate Symptom score. IIEF = International Index of Erectile Function.